Abstract: The extensive adoption of cloud computing platforms in storing and processing data have brought forth a new age of efficiency in the way data is stored, processed and managed, requiring new ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Shipping-container-based data centers have been introduced as building blocks for constructing mega-data centers. However, it is a challenge on how to interconnect those containers together with ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

In his 1960 book Theory and Design in the First Machine Age, the critic and historian Reyner Banham presciently noted a growing chasm between technological change and the capacity of designers to ...

Abstract: Hierarchical data is ubiquitous in real life, and the loading and processing of hierarchical data constitute a significant aspect of information system development. To address this common ...

CNN chief data analyst Harry Enten said on Friday morning he was shocked when seeing how much the American public believes the Republican Party cares about them, even in the wake of President Donald ...

Structure Therapeutics' stock has declined over 40% since last year, but its differentiated technology platform and promising drug pipeline still support a "Buy" rating. Structure's lead candidate, ...

Real-time data and analytics were labelled the most valued feature for traders, across all product categories and regions, in a new JP Morgan survey; findings come amid recent industry debate ...

Structure Therapeutics' GSBR-1290 showed a placebo-adjusted mean weight loss of 6.2% at 12 weeks, suggesting potential despite initial underwhelming results. Comparatively, Eli Lilly’s orforglipron ...